RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $0 | – | 3,856 | +1238.9% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 288 | -99.7% | 0.00% | -100.0% |
Q1 2022 | $585,000 | +2240.0% | 106,220 | +3943.4% | 0.00% | – |
Q4 2021 | $25,000 | -57.6% | 2,627 | +13.7% | 0.00% | – |
Q3 2021 | $59,000 | +5.4% | 2,310 | 0.0% | 0.00% | – |
Q2 2021 | $56,000 | -77.3% | 2,310 | -75.3% | 0.00% | – |
Q1 2021 | $247,000 | – | 9,345 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
Artal Group S.A. | 2,042,666 | $357 | 0.02% |
Virtu Financial LLC | 68,825 | $12 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
Citadel Advisors | 600 | $103 | 0.00% |
Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |